- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1750
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Stage I and II Small-Cell Lung Cancer—New Challenge for Surgery ; volume:200 ; number:4 ; day:30 ; month:6 ; year:2022 ; pages:505-512 ; date:8.2022
Lung ; 200, Heft 4 (30.6.2022), 505-512, 8.2022
- Urheber
-
Doerr, Fabian
Stange, Sebastian
Michel, Maximilian
Schlachtenberger, Georg
Menghesha, Hruy
Wahlers, Thorsten
Hekmat, Khosro
Heldwein, Matthias B.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00408-022-00549-8
- URN
-
urn:nbn:de:101:1-2022102422573763165390
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Doerr, Fabian
- Stange, Sebastian
- Michel, Maximilian
- Schlachtenberger, Georg
- Menghesha, Hruy
- Wahlers, Thorsten
- Hekmat, Khosro
- Heldwein, Matthias B.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities
Redefining the role of surgery in early small-cell lung cancer
Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial
Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment
First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer
Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?
The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer
Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer
First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis
Apatinib as maintenance therapy in extensive-stage small-cell lung cancer: results from a single-center retrospective study
Target engagement imaging of PARP inhibitors in small-cell lung cancer
Cost-effectiveness of the combination of immunotherapy and chemotherapy for extensive-stage small-cell lung cancer: a systematic review
Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities
Redefining the role of surgery in early small-cell lung cancer
Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial
Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment
First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer
Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?
The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer
Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer
First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis
Apatinib as maintenance therapy in extensive-stage small-cell lung cancer: results from a single-center retrospective study
Target engagement imaging of PARP inhibitors in small-cell lung cancer
Cost-effectiveness of the combination of immunotherapy and chemotherapy for extensive-stage small-cell lung cancer: a systematic review
Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities
Redefining the role of surgery in early small-cell lung cancer
Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial
Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment
First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer
Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?
The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer
Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer
First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis
Apatinib as maintenance therapy in extensive-stage small-cell lung cancer: results from a single-center retrospective study
Target engagement imaging of PARP inhibitors in small-cell lung cancer